Platelet volume indices are associated with high residual platelet reactivity after antiplatelet therapy in patients undergoing percutaneous coronary intervention

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 5, 2014, Pages 445-453

  Kim, Yun Gi ^a   Suh, Jung Won ^a   Yoon, Chang Hwan ^a   Oh, Il Young ^a   Cho, Young Seok ^a   Youn, Tae Jin ^a   Chae, In Ho ^a   Choi, Dong Ju ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Antiplatelet therapy; Platelet function test; Platelet volume

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CLOPIDOGREL; CREATININE; HEMOGLOBIN; HEMOGLOBIN A1C; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ELECTRODE AGGREGOMETRY; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION ASSAY; PLATELET DISTRIBUTION WIDTH; PLATELET REACTIVITY; RECEIVER OPERATING CHARACTERISTIC; REVASCULARIZATION; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TREATMENT OUTCOME; BLOOD; CORONARY ARTERY DISEASE; FOLLOW UP; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOCYTE;

AGED; BLOOD PLATELETS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84901479808     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.20156     Document Type: Article

References (24)

1. Suh JW, Lee SP, Park KW, et al. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial. Journal of the American College of Cardiology 2011; 57: 280-289
2. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. Journal of thrombosis and haemostasis: JTH 2010; 8: 148-156
3. van der Loo B, Martin JF. A role for changes in platelet production in the cause of acute coronary syndromes. Arteriosclerosis, thrombosis, and vascular biology 1999; 19: 672-679
4. Huczek Z, Kochman J, Filipiak KJ, et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. Journal of the American College of Cardiology 2005; 46: 284-290
5. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke; a journal of cerebral circulation 2004; 35: 1688-1691
6. Guthikonda S, Alviar CL, Vaduganathan M, et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. Journal of the American College of Cardiology 2008; 52: 743-749
7. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thrombosis and haemostasis 2006; 96: 781-788
8. Sibbing D, Braun S, Jawansky S, et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thrombosis and haemostasis 2008; 99: 121-126
9. Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS. Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention. The American journal of cardiology 2009; 103: 1339-1343
10. Park KW, Kim HS. Options to overcome clopidogrel response variability. Circulation journal: official journal of the Japanese Circulation Society 2012; 76: 287-292
11. Burr ML, Holliday RM, Fehily AM, Whitehead PJ. Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European heart journal 1992; 13: 166-170
12. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-1411
13. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. European heart journal 2001; 22: 1561-1571
14. Giles H, Smith RE, Martin JF. Platelet glycoprotein IIb- IIIa and size are increased in acute myocardial infarction. European journal of clinical investigation 1994; 24: 69-72
15. Martin JF, Shaw T, Heggie J, Penington DG. Measurement of the density of human platelets and its relationship to volume. British journal of haematology 1983; 54: 337-352
16. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
17. Casscells W. Smooth muscle cell growth factors. Progress in growth factor research 1991; 3: 177-206
18. Lee SP, Park KW, Shin DH, et al. Efficacy of predicting thrombotic events with combination of dual point-of-care testing (POCT) after drug-eluting stent implantation for coronary heart disease: results from the CILON-T randomized trial POCT substudy. Journal of atherosclerosis and thrombosis 2011; 18: 914-923
19. Ben-Dor I, Kleiman NS, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. The American journal of cardiology 2009; 104: 227-233
20. Kereiakes DJ, Gurbel PA. Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention. JACC Cardiovascular interventions 2008; 1: 111-121
21. Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Platelet function monitoring in patients with coronary artery disease. Journal of the American College of Cardiology 2007; 50: 1822-1834
22. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008; 336: 195-198
23. Ko YG, Suh JW, Kim BH, et al. Comparison of 2 pointof- care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention. American heart journal 2011; 161: 383-390
24. Jeong YH, Tantry US, Kim IS, et al. Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin. Circulation Cardiovascular interventions 2011; 4: 585-594